CN Patent
CN105777586A — S(+)氨己烯酸酯衍生物及其制备方法和用途
Assigned to Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd · Expires 2016-07-20 · 10y expired
What this patent protects
本发明提供了(4S)‑‑4‑(((1‑(异丁酰氧基)乙氧基)羰基)氨基)‑5‑己烯酸衍生物(式I)或其药学上可接受的盐及其制备方法和用途。属于有机化合物合成及医药应用技术领域。本发明还提供该S(+)氨己烯酸酯衍生物的应用方法和将该衍生物的药物组合物用于治疗或预防常见病和/或病症的方法。
USPTO Abstract
本发明提供了(4S)‑‑4‑(((1‑(异丁酰氧基)乙氧基)羰基)氨基)‑5‑己烯酸衍生物(式I)或其药学上可接受的盐及其制备方法和用途。属于有机化合物合成及医药应用技术领域。本发明还提供该S(+)氨己烯酸酯衍生物的应用方法和将该衍生物的药物组合物用于治疗或预防常见病和/或病症的方法。
Drugs covered by this patent
- Horizant (GABAPENTIN ENACARBIL) · Azurity
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.